Press releasePRNewswire
Bausch Health Companies
BHC · TORONTO
$6.42+$0.10 (+1.58%)TodayMarket closed ·
Prev close $6.32
Latest news
- NewsNeeraj Jain
Why Is Bausch + Lomb Stock Falling Monday?
- Press releasePRNewswire
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway
- Press releaseBusiness Wire
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
- Press releasePRNewswire
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026
- Press releasePRNewswire
Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets
- Press releasePRNewswire
(Pr)SILIQ® (brodalumab injection) Now Reimbursed Under Alberta's Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis
- Press releasePRNewswire
Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia
- Press releasePRNewswire
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
- Press releaseGlobe Newswire
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
- NewsErica Kollmann
This Hedge Fund Portfolio Shrinks 17% as Billionaire Bets Big on Gold
- Press releasePRNewswire
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
- Press releasePRNewswire
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate
- Press releasePRNewswire
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
- Press releasePRNewswire
(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis
- Press releasePRNewswire
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
- Press releasePRNewswire
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia
- Press releasePRNewswire
Michael Goettler Resigns from Bausch Health's Board of Directors
- Press releasePRNewswire
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia
- Press releasePRNewswire
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
- Press releasePRNewswire
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
- Press releasePRNewswire
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
- Press releasePRNewswire
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
- News
Bausch Health Companies Q1 Adj. EPS $0.78 Beats $0.69 Estimate, Sales $2.524B Beat $2.409B Estimate
- Press releasePRNewswire
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
- News
Earnings Scheduled For April 29, 2026
- Press releasePRNewswire
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering
- Press releasePRNewswire
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
- Press releasePRNewswire
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program
- News
Insights into Bausch Health Companies Q4 Earnings
- News
Bausch Health Companies Q4 Earnings Report: What Investors Need to Know
- Press releasePRNewswire
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
- NewsAvi Kapoor
Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday
- NewsSurbhi Jain
Carl Icahn's Biggest Bet Just Torched Half His Fortune
- Press releaseACCESS Newswire
Bausch Health Announces Third Quarter 2025 Results
- NewsErica Kollmann
Retail Investors' Top Stocks With Earnings This Week: SoFi, Apple, Meta And More
- Press releaseACCESS Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
- News
A Look Into Bausch Health Companies Inc's Price Over Earnings
- NewsSurbhi Jain
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited
- Press releaseACCESS Newswire
Bausch Health Announces Second Quarter 2025 Results
- Press releaseACCESS Newswire
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
- NewsAvi Kapoor
GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday
- NewsSurbhi Jain
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
- Press releaseACCESS Newswire
Bausch Health Announces First Quarter 2025 Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.